Literature DB >> 12127603

A comparison of clinical ratings with vocal acoustic measures of flat affect and alogia.

Murray Alpert1, Richard J Shaw, Enrique R Pouget, Kelvin O Lim.   

Abstract

In this report we compare clinical ratings of flat affect and alogia with objective measures of the patient's speech prosody and productivity. Thirty schizophrenic patients were evaluated with the Scale for the Assessment of Negative Symptoms (SANS) and the St. Hans Rating Scale for extra pyramidal side effects. Their speech was recorded and analyzed acoustically for measures of prosody and productivity. Correlations between pairs of SANS items and acoustic measures (e.g. Vocal Inflection and Fundamental Frequency Variance) were weak. The SANS item and global ratings were strongly related. Ratings of bradykinesia overlapped with the SANS ratings but not with the acoustic measures. The SANS ratings appear to be derived from global impressions, with diffuse confounding of flat affect with alogia, and with bradykinesia. Acoustic analysis has the potential to provide objective measures that may help develop operational definitions of these constructs and enhance clinical assessment.

Entities:  

Mesh:

Year:  2002        PMID: 12127603     DOI: 10.1016/s0022-3956(02)00016-x

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  18 in total

Review 1.  Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research.

Authors:  Julie W Messinger; Fabien Trémeau; Daniel Antonius; Erika Mendelsohn; Vasthie Prudent; Arielle D Stanford; Dolores Malaspina
Journal:  Clin Psychol Rev       Date:  2010-09-18

Review 2.  What do we really know about blunted vocal affect and alogia? A meta-analysis of objective assessments.

Authors:  Alex S Cohen; Kyle R Mitchell; Brita Elvevåg
Journal:  Schizophr Res       Date:  2014-09-26       Impact factor: 4.939

3.  Psychiatric symptom versus neurocognitive correlates of diminished expressivity in schizophrenia and mood disorders.

Authors:  Alex S Cohen; Yunjung Kim; Gina M Najolia
Journal:  Schizophr Res       Date:  2013-03-06       Impact factor: 4.939

4.  The aprosody of schizophrenia: Computationally derived acoustic phonetic underpinnings of monotone speech.

Authors:  Michael T Compton; Anya Lunden; Sean D Cleary; Luca Pauselli; Yazeed Alolayan; Brooke Halpern; Beth Broussard; Anthony Crisafio; Leslie Capulong; Pierfrancesco Maria Balducci; Francesco Bernardini; Michael A Covington
Journal:  Schizophr Res       Date:  2018-02-12       Impact factor: 4.939

5.  A Psychometric Comparison of the Clinical Assessment Interview for Negative Symptoms and the Brief Negative Symptom Scale.

Authors:  Gregory P Strauss; James M Gold
Journal:  Schizophr Bull       Date:  2016-05-12       Impact factor: 9.306

6.  Vocal expression in schizophrenia: Less than meets the ear.

Authors:  Alex S Cohen; Kyle R Mitchell; Nancy M Docherty; William P Horan
Journal:  J Abnorm Psychol       Date:  2016-02

7.  The assessment of nonverbal behavior in schizophrenia through the Formal Psychological Assessment.

Authors:  Umberto Granziol; Andrea Spoto; Giulio Vidotto
Journal:  Int J Methods Psychiatr Res       Date:  2017-11-03       Impact factor: 4.035

8.  Voice acoustic measures of depression severity and treatment response collected via interactive voice response (IVR) technology.

Authors:  James C Mundt; Peter J Snyder; Michael S Cannizzaro; Kara Chappie; Dayna S Geralts
Journal:  J Neurolinguistics       Date:  2007-01       Impact factor: 1.710

9.  Computerized measurement of negative symptoms in schizophrenia.

Authors:  Alex S Cohen; Murray Alpert; Tasha M Nienow; Thomas J Dinzeo; Nancy M Docherty
Journal:  J Psychiatr Res       Date:  2007-10-24       Impact factor: 4.791

10.  Phonetic measures of reduced tongue movement correlate with negative symptom severity in hospitalized patients with first-episode schizophrenia-spectrum disorders.

Authors:  Michael A Covington; S L Anya Lunden; Sarah L Cristofaro; Claire Ramsay Wan; C Thomas Bailey; Beth Broussard; Robert Fogarty; Stephanie Johnson; Shayi Zhang; Michael T Compton
Journal:  Schizophr Res       Date:  2012-10-24       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.